HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A Dabisch Selected Research

Paul A Dabisch Research Topics

Disease

3Miosis
11/2007 - 02/2006
1COVID-19
01/2021
1Infections
11/2017
1Anthrax
11/2017
1Communicable Diseases (Infectious Diseases)
11/2017
1Seizures (Absence Seizure)
12/2011
1Poisoning
09/2008
1Tachycardia (Tachyarrhythmias)
09/2007
1Cocaine-Related Disorders (Cocaine Addiction)
11/2005
1Stroke (Strokes)
10/2003
1Myocardial Infarction
10/2003

Drug/Important Bio-Agent (IBA)

3SarinIBA
12/2011 - 02/2006
2ButyrylcholinesteraseIBA
12/2011 - 09/2008
2Nerve AgentsIBA
10/2006 - 02/2006
1VaccinesIBA
01/2021
1Indicators and Reagents (Reagents)IBA
11/2017
1Pharmaceutical PreparationsIBA
09/2008
1OrganophosphatesIBA
09/2008
1SomanIBA
11/2007
1AtropineFDA LinkGeneric
09/2007
1Biomarkers (Surrogate Marker)IBA
10/2006
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2006
1cyclohexyl methylphosphonofluoridate (cyclosarin)IBA
02/2006
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
11/2005
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2005
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
11/2005
1Cocaine (Cocaine HCl)IBA
11/2005
1Isoproterenol (Isoprenaline)FDA LinkGeneric
11/2005
1Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2005
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
11/2005
1Vasodilator Agents (Vasodilators)IBA
11/2005
1EphedrineFDA LinkGeneric
10/2003

Therapy/Procedure

1Therapeutics
01/2021
1Euthanasia (Mercy Killing)
11/2017